Fundz

CERo Therapeutics Holdings reported raising $5 Million in an initial SEC Form D filing, from an offering of $8 Million

PUBLIC · CEROMay 06, 2025

Amount Raised

$5 Million

$5 Million per company press release (Jun 6, 2025)

Round Type

Venture

San FranciscoOtherBiotechnologyHealth CareTherapeutics

Who to call at CERo Therapeutics Holdings, and when

A new round usually means CERo Therapeutics Holdings is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CERo Therapeutics Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CERo Therapeutics Holdings, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CERo Therapeutics Holdings

Location

San Francisco, California, United States

About

CERo Therapeutics Holdings, Inc. is an innovative immunotherapy company focused on advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering is designed to engage the body’s full immune repertoire to achieve optimized cancer therapy, redirecting patient-derived T cells to eliminate tumors by employing phagocytic mechanisms. CERo anticipates initiating clinical trials for its lead product candidate, CER-1236, in 2024 for hematological malignancies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CERo Therapeutics Holdings raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts3 people are listed at CERo Therapeutics Holdings. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CERo Therapeutics Holdings's next move

See what Strategic adds

CERo Therapeutics Holdings raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.